Heme oxygenase-1 is a predictive biomarker for therapeutic targeting of advanced clear cell renal cell carcinoma treated with sorafenib or sunitinib

References

• JemalASiegelRXuJWardECancer statistics, 2010CA Cancer J Clin201060527730020610543
   PubMed Web of Science ®Google Scholar
• KoulHHuhJSRoveKOMolecular aspects of renal cell carcinoma: a reviewAm J Cancer Res20111224025421969126
   PubMed Web of Science ®Google Scholar
• ZhaoJZhuYZhangCSorafenib or sunitinib as postoperative adjuvant therapy for Chinese patients with locally advanced clear cell renal cell carcinoma at high risk for disease recurrenceUrol Oncol20133181800180522658883
   PubMed Web of Science ®Google Scholar
• CoppinCPorzsoltFAwaAKumpfJColdmanAWiltTImmuno-therapy for advanced renal cell cancer [review]Cochrane Database Syst Rev20051CD00142515674877
   PubMed Web of Science ®Google Scholar
• JemalASiegelRWardECancer statistics, 2006CA Cancer J Clin200656210613016514137
   PubMed Web of Science ®Google Scholar
• ChouhanJDZamarripaDELaiPHOramasionwuCUGrabinskiJLSunitinib (Sutent): a novel agent for the treatment of metastatic renal cell carcinomaJ Oncol Pharm Pract200713151517621562
   PubMedGoogle Scholar
• AbramsTJLeeLBMurrayLJPryerNKCherringtonJMSU11248 inhibits KIT and platelet-derived growth factor receptor beta in preclinical models of human small cell lung cancerMol Cancer Ther20032547147812748309
   PubMed Web of Science ®Google Scholar
• WilhelmSMAdnaneLNewellPVillanuevaALlovetJMLynchMPreclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signalingMol Cancer Ther20087103129314018852116
   PubMed Web of Science ®Google Scholar
• ReddyKPhase III study of sunitinib malate (SU11248) versus interferon-alpha as first-line treatment in patients with metastatic renal cell carcinomaClin Genitourin Cancer200651232516859575
   PubMed Web of Science ®Google Scholar
• YouDSongSHChoYMPredictive role of tissue-based molecular markers in patients treated with sunitinib for metastatic renal cell carcinomaWorld J Urol201533111111824710685
   PubMed Web of Science ®Google Scholar
• HjortsøMDAndersenMHThe expression, function and targeting of haem oxygenase-1 in cancerCurr Cancer Drug Targets201414433734724655000
   PubMed Web of Science ®Google Scholar
• WasHCichonTSmolarczykROverexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of miceAm J Pathol200616962181219817148680
   PubMed Web of Science ®Google Scholar
• NuhnPKünzliBMHennigRHeme oxygenase-1 and its metabolites affect pancreatic tumor growth in vivoMol Cancer200983719508729
   PubMed Web of Science ®Google Scholar
• SassGLeukelPSchmitzVInhibition of heme oxygenase 1 expression by small interfering RNA decreases orthotopic tumor growth in livers of miceInt J Cancer200812361269127718566988
   PubMed Web of Science ®Google Scholar
• BalanMMiery TeranEWaaga-GasserAMNovel roles of c-Met in the survival of renal cancer cells through the regulation of HO-1 and PD-L1 expressionJ Biol Chem2015290138110812025645920
   PubMed Web of Science ®Google Scholar
• BanerjeePBasuADattaDGasserMWaaga-GasserAMPalSThe heme oxygenase-1 protein is overexpressed in human renal cancer cells following activation of the Ras-Raf-ERK pathway and mediates anti-apoptotic signalJ Biol Chem201128638335803359021808062
   PubMed Web of Science ®Google Scholar
• WasHDulakJJozkowiczAHeme oxygenase-1 in tumor biology and therapyCurr Drug Targets201011121551157020704546
   PubMed Web of Science ®Google Scholar
• EisenhauerEATherassePBogaertsJNew response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)Eur J Cancer200945222824719097774
   PubMed Web of Science ®Google Scholar
• RiniBIVascular endothelial growth factor-targeted therapy in renal cell carcinoma: current status and future directionsClin Cancer Res20071341098110617317817
   PubMed Web of Science ®Google Scholar
• GrandinettiCAGoldspielBRSorafenib and sunitinib: novel targeted therapies for renal cell cancerPharmacotherapy20072781125114417655513
   PubMed Web of Science ®Google Scholar
• UchidaKMiyaoNMasumoriNRecurrence of renal cell carcinoma more than 5 years after nephrectomyInt J Urol200291192311972645
   PubMed Web of Science ®Google Scholar
• WysockiPJmTOR in renal cell cancer: modulator of tumor biology and therapeutic targetExpert Rev Mol Diagn20099323124119379082
   PubMed Web of Science ®Google Scholar
• WoodLSNew therapeutic strategies for renal cell carcinomaUrol Nurs2010301405320359144
   PubMedGoogle Scholar
• CohenHTMcGovernFJRenal-cell carcinomaNew Engl J Med2005353232477249016339096
   PubMed Web of Science ®Google Scholar
• KlapperJADowneySGSmithFOHigh-dose interleukin-2 for the treatment of metastatic renal cell carcinoma: a retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006Cancer2008113229330118457330
   PubMed Web of Science ®Google Scholar
• GeertsenPFGoreMENegrierSTouraniJMvon der MaaseHSafety and efficacy of subcutaneous and continuous intravenous infusion rIL-2 in patients with metastatic renal cell carcinomaBr J Cancer20049061156116215026795
   PubMed Web of Science ®Google Scholar
• HutsonTEQuinnDICytokine therapy: a standard of care for metastatic renal cell carcinoma?Clin Genitourin Cancer20054318118616425986
   PubMedGoogle Scholar
• ChoDCPrognostic biomarkers for patients with advanced renal cell carcinoma treated with VEGF-targeted tyrosine kinase inhibitorsOnco Targets Ther2013667968423788835
   PubMed Web of Science ®Google Scholar
• JozkowiczAWasHDulakJHeme oxygenase-1 in tumors: is it a false friend?Antioxid Redox Signal20079122099211717822372
   PubMed Web of Science ®Google Scholar
• EscudierBEisenTStadlerWMTARGET Study GroupSorafenib in advanced clear-cell renal-cell carcinomaNew Engl J Med2007356212513417215530
   PubMed Web of Science ®Google Scholar
• ZimmermannKSchmittelASteinerUSunitinib treatment for patients with advanced clear-cell renal-cell carcinoma after progression on sorafenibOncology200976535035419321976
   PubMed Web of Science ®Google Scholar
• MotzerRJMichaelsonMDRosenbergJSunitinib efficacy against advanced renal cell carcinomaJ Urol200717851883188717868732
   PubMed Web of Science ®Google Scholar
• MotzerRJHutsonTETomczakPSunitinib versus interferon alfa in metastatic renal-cell carcinomaNew Engl J Med2007356211512417215529
   PubMed Web of Science ®Google Scholar
• MotzerRJAgarwalNBeardCNCCN clinical practice guidelines in oncology: kidney cancerJ Natl Compr Canc Netw20097661863019555584
   PubMed Web of Science ®Google Scholar
• ZhangHDongBLuJJEfficacy of sorafenib on metastatic renal cell carcinoma in Asian patients: results from a multicenter studyBMC Cancer2009924919622166
   PubMed Web of Science ®Google Scholar